TransCon Growth Hormone or TransCon hGH is now approved in the US by the FDA for the replacement of endogenous growth hormone ...
Management reported that "meaningful" open bids were both awarded and lost during recent contract cycles, citing a strict focus on profitability and a readiness to capitalize on service failures by ...
Jugal will provide opening comments on the quarter and full year. Following Jugal, Shelly will review the detailed financial results in addition to discussing expectations for 2026. The company’s ...
Key Strategic Drivers: 3D EXPERIENCE software revenue increased by 10%, representing 41% of 3D EXPERIENCE Eligible software revenue. Cloud software revenue grew 8% in non-IFRS (7% in IFRS), and ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
From the comments made in past months, Gold's larger rally phase was projected to hold up into February of this year, plus or minus, though with the recent 'mini-panic' drop well overdue in the Gold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results